Beacon Pointe Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Hold |
2,428
| – | – | ﹤0.01% | 1151 |
|
|
2025
Q1 | $221K | Hold |
2,428
| – | – | ﹤0.01% | 1104 |
|
|
2024
Q4 | $209K | Hold |
2,428
| – | – | ﹤0.01% | 1123 |
|
|
2024
Q3 | $231K | Hold |
2,428
| – | – | ﹤0.01% | 1100 |
|
|
2024
Q2 | $222K | Hold |
2,428
| – | – | ﹤0.01% | 1145 |
|
|
2024
Q1 | $220K | Buy |
+2,428
| New | +$220K | ﹤0.01% | 1207 |
|
|
2023
Q2 | – | Sell |
-3,371
| Closed | -$262K | – | 1160 |
|
|
2023
Q1 | $262K | Buy |
3,371
+318
| +10% | +$24.7K | ﹤0.01% | 981 |
|
|
2022
Q4 | $237K | Hold |
3,053
| – | – | ﹤0.01% | 945 |
|
|
2022
Q3 | $207K | Hold |
3,053
| – | – | ﹤0.01% | 919 |
|
|
2022
Q2 | $235K | Buy |
3,053
+350
| +13% | +$26.9K | 0.01% | 917 |
|
|
2022
Q1 | $216K | Buy |
+2,703
| New | +$216K | ﹤0.01% | 1096 |
|